IBAL yields 118.34% · ABBV yields 3.06%● Live data
📍 IBAL pulled ahead of the other in Year 1
Combined, IBAL + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of IBAL + ABBV for your $10,000?
International Baler Corporation manufactures and sells baling equipment to compress various materials into bales for handling, shipping, disposal, storage, and recycling. The company offers general purpose horizontal and vertical balers for compaction of paper, corrugated boxes, and miscellaneous solid waste materials; and specialty balers, including scrap metal, drum crusher, textile, and double chamber balers that are used for textile materials, used clothing, aluminum cans, 55-gallon drums, and synthetic rubber. It also provides accessory equipment comprising conveyors, which carry waste from floor level to the top of horizontal balers; extended hoppers on such balers; rufflers, which break up material; electronic start/stop controls; hydraulic oil coolers and cleaners; fluffers; bale tying machines; and plastic bottle piercers, as well as service and repair work to general purpose and specialty balers. The company sells its products to waste producing retailers, manufacturing and fabricating plants, bulk material producers, solid waste recycling facilities, manufacturers of synthetic rubber and polymers, plastic and paper recycling facilities, textile and paper mills, power generating facilities, cotton gins, supermarkets and other retail outlets, and municipalities. In addition, the company markets its products through sales force, manufacturer's representatives, and dealers in the United States, Europe, the Far East, South America, and internationally. The company was formerly known as Waste Technology Corporation and changed its name to International Baler Corporation in March 2009. International Baler Corporation was founded in 1946 and is based in Jacksonville, Florida. International Baler Corporation is a subsidiary of Avis Industrial Corporation.
Full IBAL Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.